NMDA receptor antibodies
Autoantibodies to the N-methyl-d-aspartate receptor (NMDAR). NMDAR antibodies were first reported in young female patients with ovarian tumours and prominent psychiatric symptoms, amnesia, seizures etc. The antibodies are now also reported in males or females with no known tumour
| Tube | Serum Gel |
|---|---|
| ID | 12821 |
| Additional Information | The presence of these antibodies suggests an immunotherapy-responsive condition. For further information please refer to: Dalmau et al. Lancet Neurol. 2008 Dec; 7 (12): 1091-8. |
| Turn Around | Refer to relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results (estimated 28days) |
| Send to | Samples should be sent to the department of Clinical Immunology at LGI who will refer to appropriate referral lab (Sheffield PRU) |
| Collection Con | No restrictions |
| Frequency | Referred to external laboratory |
| Sample REQ | Serum |
| Ref. Range (Male) | NA Interpretive |
| Ref. Range (Female) | NA Interpretive |
| Ref. Range (Paed) | NA Interpretive |
| Ref. Range Notes | Positive/Negative |
| Units | NA |
| IP Acute TAT | Contact referral laboratory. Contact Immunology at LGI if sample is to be sent urgently. |
| IP Routine TAT | Refer to relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results. |
| GP Acute TAT | Contact referral laboratory. Contact Immunology at LGI if sample is to be sent urgently. |
| GP Routine TAT | Refer to relevant laboratory for up to date turn around times, allowing an additional 10 working days for samples processing, dispatch and reporting and validation of the results. |
| Telepath | NMDA1L |
| ICE Codes | INMDA |
